Browse our collection of papers in
GlaxoSmithKline (GSK)

Select number of records per page:  

C/B/4525. Strategic analysis of UK pharmaceutical industry and its competitive environment

WORDS:
8600
DATE:
2012
PRICE:
89.99 GBP

The paper looks at the UK pharmaceutical industry and its competitive environment providing a general overview of the industry, describing the major pharmaceutical companies, i.e. AstraZeneca (AZ), GlaxoSmithKline (GSK), and Pfizer (PF), and conducting strategic analysis of the industry along the lines of STEEP (PESTLE) and Porter’s Five Forces models.

 

KEYWORDS: Strategic analysis, UK pharmaceutical industry, competitive environment, STEEP, PESTLE, Porter’s Five Forces, AstraZeneca, AZ, GlaxoSmithKline, GSK, Pfizer, PF,

 

C/B/4464. PESTEL, Porter's 5 Forces, SWOT and Value Chain analyses of GlaxoSmithKline

WORDS:
3150
DATE:
2012
PRICE:
39.99 GBP

This paper presents a comprehensive analysis of GlaxoSmithKline. Firstly the paper presents an overview of GlaxoSmithKline followed by PESTEL analysis which identifies the Political, Economic, Social, Technological, Environmental and Legal aspects of business environments. Porter’s Five Forces analysis is provided, discussing the competitiveness of the industry. SWOT analysis is used to evaluate the strengths, weaknesses, opportunities and threats to GlaxoSmithKline. The paper also consists of Value Chain analysis looking at the key activities of GlaxoSmithKline.

 

KEYWORDS: PEST, PESTEL, PESTLE, SWOT, Porter, 5 forces, TOWS, Value Chain, GlaxoSmithKline, GSK,

 

C/B/4463. Porter's 5 Forces analysis of GlaxoSmithKline

WORDS:
950
DATE:
2012
PRICE:
9.99 GBP

This paper analyses GlaxoSmithKline, using Porter’s Five Forces analysis. Firstly an overview of the company is presented. Porter’s 5 forces analysis concentrates on the bargaining power of customers, bargaining power of suppliers, threat of new entrants, threat of substitute products, and intensity of competitive rivalry affecting GlaxoSmithKline.

 

KEYWORDS: Porter, 5 forces, five forces, GlaxoSmithKline, GSK,

 

C/B/4462. PESTEL and Porter's 5 Forces analyses of GlaxoSmithKline

WORDS:
1800
DATE:
2012
PRICE:
19.99 GBP

This paper critically analyses GlaxoSmithKline, providing an overview of the company followed by PESTEL and Porter’s Five Forces analyses. The PESTEL analysis assesses Political, Economic, Social, Technological, Environmental and Legal factors affecting GlaxoSmithKline. Porter's 5 Forces analysis discusses the bargaining power of customers, bargaining power of suppliers, threat of new entrants, threat of substitute products, and intensity of competitive rivalry of GlaxoSmithKline.

 

KEYWORDS: PEST, PESTEL, PESTLE, Porter, 5 forces, five forces, GlaxoSmithKline, GSK,

 

C/B/4461. Value chain analysis of GlaxoSmithKline

WORDS:
1000
DATE:
2012
PRICE:
19.99 GBP

This paper presents an overview of GlaxoSmithKline, using Value Chain Analysis. This is a management tool used to identify key activities within an organisation which forms its value chain: Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development, and firm infrastructure.

 

KEYWORDS: Value Chain, Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development and firm infrastructure, GlaxoSmithKline, GSK,

 

C/B/4460. SWOT and Value Chain Analyses of GlaxoSmithKline

WORDS:
1800
DATE:
2012
PRICE:
19.99 GBP

This paper provides an overview of GlaxoSmithKline, followed by a SWOT analysis which evaluates its strengths, weaknesses, opportunities and threats. A Value Chain Analysis of GlaxoSmithKline is conducted to outline Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development, and firm infrastructure.

 

KEYWORDS: SWOT, TOWS, Value Chain, Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development and firm infrastructure, GlaxoSmithKline, GSK,

 

C/B/4459. SWOT analysis of GlaxoSmithKline

WORDS:
1250
DATE:
2012
PRICE:
19.99 GBP

This paper evaluates GlaxoSmithKline, using a detailed SWOT analysis. This analysis is conducted to audit GlaxoSmithKline and its environment, and focuses on the strengths, weaknesses, opportunities and threats of GlaxoSmithKline.

 

KEYWORDS: SWOT, TOWS, GlaxoSmithKline, GSK,

 

C/B/4458. PESTEL and SWOT analyses of GlaxoSmithKline

WORDS:
2150
DATE:
2012
PRICE:
29.99 GBP

This paper provides PESTEL and SWOT analyses of GlaxoSmithKline. Firstly the paper gives an overview of GlaxoSmithKline. Secondly the PESTEL analysis of GlaxoSmithKline is provided identifying Political, Economic, Social, Technological, Environmental and Legal factors affecting GlaxoSmithKline. Lastly the paper outlines SWOT analysis identifying strengths, weaknesses, opportunities and threats of GlaxoSmithKline.

 

KEYWORDS: PESTEL, PEST, SWOT, TOWS, GlaxoSmithKline, GSK,

 

C/B/4457. PESTEL analysis of GlaxoSmithKline

WORDS:
1300
DATE:
2012
PRICE:
19.99 GBP

This paper presents an overview of GlaxoSmithKline using PESTEL analysis, which identifies the Political, Economic, Social, Technological, Environmental and Legal factors affecting GlaxoSmithKline.

 

KEYWORDS: PEST, PESTEL, PESTLE, GlaxoSmithKline, GSK,

 

C/B/4456. Strategic Analysis of GlaxoSmithKline

WORDS:
2600
DATE:
2012
PRICE:
29.99 GBP

This paper analyses GlaxoSmithKline. The paper consists of an overview of GlaxoSmithKline, followed by PESTEL analysis, which identifies the Political, Economic, Social, Technological, Environmental and Legal factors of the company. SWOT analysis is used to evaluate the strengths, weaknesses, opportunities and threats to GlaxoSmithKline. Porter's 5 Forces analysis of GlaxoSmithKline is presented, discussing the bargaining power of customers, bargaining power of suppliers, threat of new entrants, threat of substitute products, and intensity of competitive rivalry affecting GlaxoSmithKline.

 

KEYWORDS: PEST, PESTEL, PESTLE, SWOT, Porter, 5 forces, TOWS, GlaxoSmithKline, GSK,

 

C/F/1281. Financial analysis of GlaxoSmithKline and Phytopharm Plc between the years 2008-2010

WORDS:
2650
DATE:
2011
PRICE:
29.99 GBP

This paper performs a financial analysis of two pharmaceutical companies, GlaxoSmithKline (GSK) and Phytopharm Plc. The company’s financial data is examined between the periods of 2008-2010. The paper looks at a variety of ratios, some of which include the quick ratio, the gearing ratio, and the inventory ratio. Both companies’ annual reports are examined, and the paper then evaluates the findings.

 

KEYWORDS: Financial analysis, pharmaceutical, GlaxoSmithKline, Phytopharm Plc, quick ratio, the gearing ratio, inventory ratio,

 

C/F/1204. Financial analysis of GlaxoSmithKline and AstraZeneca

WORDS:
2600
DATE:
2011
PRICE:
29.99 GBP

The paper examines the financial performance of two pharmaceutical companies, GlaxoSmithKline (GSK) and AstraZeneca (AZN) conducting their ratio analysis for 2009 and comparing their financial indices on the basis of the analysis. Recommendations are suggested to the companies’ management and investors.

 

KEYWORDS: Financial analysis, financial ratios, GlaxoSmithKline, GSK, AstraZeneca, AZN,

 

C/M/2173. The reasons why the study of organisations is important

WORDS:
650
DATE:
2011
PRICE:
9.99 GBP

This paper discuses the reasons why studying organisations is important. The paper introduces the concept of organisations, and follows with a discussion regarding management theories. Some of the theories discussed include enterprise architecture and the agency theory. The paper examines aspects regarding GlaxoSmithKline and The Cooperative and concludes with the writers personal opinions on the subject.

 

KEYWORDS: Organisations, management theories, enterprise architecture, agency theory, GlaxoSmithKline, The Cooperative,

 

S/F/288. Financial report on GlaxoSmithKline

WORDS:
1500
DATE:
2011
PRICE:
19.99 GBP

The paper presents financial analysis of GlaxoSmithKline (GSK) for 2006-2009 describing the profile of the company, reporting on their financial performance during 2009, and conducting analysis of their financial ratios for 2006-2008. GSK performance is compared to that of Johnson & Johnson (J&J), the main competitor of GSK, suggesting investment in GSK.

 

KEYWORDS: Financial report, GlaxoSmithKline, GSK, Johnson & Johnson, J&J,

 

C/B/3482. SWOT analysis of Aquafresh

WORDS:
1200
DATE:
2011
PRICE:
19.99 GBP

This paper evaluates Aquafresh, using a detailed SWOT analysis. This analysis is conducted to audit Aquafresh and its environment, and focuses on the strengths, weaknesses, opportunities and threats of Aquafresh.

 

KEYWORDS: SWOT, TOWS, Aquafresh,

 

C/B/3473. PESTEL analysis of Aquafresh

WORDS:
1050
DATE:
2011
PRICE:
19.99 GBP

This paper presents an overview of Aquafresh using PESTEL analysis, which identifies the Political, Economic, Social, Technological, Environmental and Legal factors affecting Aquafresh.

 

KEYWORDS: PEST, PESTEL, PESTLE, Aquafresh,

 

C/M/1921. Marketing Mix for Aquafresh

WORDS:
1200
DATE:
2011
PRICE:
19.99 GBP

This paper presents a detailed marketing mix for Aquafresh, and the paper begins by providing the background to the company. The four P’s of marketing are assessed in reference to the organization, namely Product, Price, Place, and Promotion

 

KEYWORDS: Marketing mix, Aquafresh, Product, Price, Place, Promotion,

 

C/F/1004. Financial analysis of GlaxoSmithKline

WORDS:
1300
ADD-ONS:
Excel Data
DATE:
2011
PRICE:
19.99 GBP

This paper evaluates the financial performance of GlaxoSmithKline, focusing on their performance for the financial years 2007-2009. The paper presents an overview of GlaxoSmithKline followed by the analysis of suitable financial ratios of GlaxoSmithKline including interest ratios, gearing ratios, and current ratios. The second part of this paper provides a comprehensive analysis of share performance of GlaxoSmithKline and forecast of share performance for the next 12 months. All calculations are provided in the appendix.

 

KEYWORDS: Financial Analysis, Share Performance, Financial Ratios, GlaxoSmithKline,

 

C/M/1831. Strategic analysis of Aquafresh

WORDS:
3400
DATE:
2010
PRICE:
39.99 GBP

This paper aims to examine the toothpaste Aquafresh, as well as discussing the toothpaste industry in general. The paper begins by providing the background to the company and their products, and this is then followed by a SWOT analysis. The company’s competitive edge is discussed, and the paper then performs a PESTEL analysis. Recommendations for future improvement are suggested in relation to segmentation, targeting and positioning. The main marketing objectives and goals are identified through the SMART framework, and the paper also provides the marketing mix for the company. Conclusions are made regarding the success of the company.

 

KEYWORDS: Toothpaste, Aquafresh, toothpaste industry, SWOT, PESTEL, competitors, segmentation, targeting, positioning, SMART framework, marketing mix,

 

C/F/973. Credit Rating Analysis of GlaxoSmithKline

WORDS:
1600
DATE:
2010
PRICE:
19.99 GBP

The paper looks at the rating agencies that provide ratings on credit worthiness of companies. The relevance of the rating industry is examined discussing the fairness and accuracy of the ratings. A case study is conducted comparing credit rating analysis of GlaxoSmithKline (GSK) given by the two rating agencies on the basis of the company’s financial ratios. Financial risks embedded in the GSK profile are defined, financial challenges of the pharmaceutical industry are discussed.

 

KEYWORDS: Credit Rating, rating agency, GlaxoSmithKline, GSK, financial ratios,

 

C/B/3259. Strategic capability of GlaxoSmithKline

WORDS:
1300
DATE:
2010
PRICE:
19.99 GBP

The paper examines the sources of competitive advantage used by GlaxoSmithKline (GSK) identifying their core competences and capabilities, analyzing the company’s product development strategy using the Ansoff matrix, and categorizing GSK stakeholders on the basis of the Mendelow matrix.

 

KEYWORDS: Strategic capability, GlaxoSmithKline, GSK, Competitive Advantage, Ansoff Matrix, Mendelow Matrix,

 

C/OM/271. Operational management in GlaxoSmithKline

WORDS:
4000
DATE:
2010
PRICE:
49.99 GBP

This paper analyses the practical issues faced by firms from operational perspectives, providing key recommendations for improvement. GlaxoSmithKline (GSK) is used as a case study for research and development (R&D). Operations management in the Pharmaceutical industry is discussed, followed by an overview of GSK. Operational strategy, issues within the R&D Department, operational change, R&D Process mapping, and key performance objectives are discussed. The paper concludes with recommendations and conclusions.

 

KEYWORDS: GlaxoSmithKline, GSK, research and development, R&D, Operations Management,

 

C/F/815. Use of CAPM in measuring investment opportunities of M&S and GSK

WORDS:
2250
DATE:
2010
PRICE:
29.99 GBP

The paper looks at the corporate and international financial measures used to minimise risks associated with investment decisions examining Marks and Spencer (M&S) and GlaxoSmithKline (GSK) as investment opportunities. The use of financial measurement tools includes the calculation and comparison of Beta for the stocks of both companies using the Capital Asset Pricing Model (CAPM).

 

KEYWORDS: Marks and Spencer, M&S, GlaxoSmithKline, GSK, Investment Decisions, Capital Asset Pricing Model, CAMP,

 

C/HR/744. Dissertation. Communication challenges arising from off shoring to India. GSK case study.

WORDS:
13400
DATE:
2010
PRICE:
139.99 GBP

This dissertation looks at the off shoring of US and UK firms to India for selected activities, in particular IT outsourcing. The dissertation is focused on a case study of GlaxoSmithKline (GSK) and the company’s initiative of offshoring part of their activities. The dissertation outlines how offshoring provides a number of benefits to firms such as lowering the cost of services as well as concentrating the skills and capabilities of specific functions in one area, and these benefits are expected to ensure that firms will continue to pursue offshoring as part of their overall strategy. The dissertation addresses the following issues: Understand the communications and training challenges that US and UK firms faced in their transactions with Indian IT vendor personnel, Assess the communications between the US and UK personnel with their India counterparts, and provide recommendations to address the challenges identified in the communications and training related to off shoring of functions. A literature review is followed by the use of conversation analysis (ca) to analyse cross-cultural communications.

 

KEYWORDS: Dissertation, Offshoring, India, GSK, GlaxoSmithKline communication challenges, IT outsourcing, conversation analysis, CA, HRO, human resource outsourcing, international business, international culture, cross cultural,

 

C/M/1543. Disaster and security management: theory and case studies

WORDS:
3550
DATE:
2010
PRICE:
39.99 GBP

The paper looks at the practices of disaster and security management (DSM) examining case studies related to different areas of DSM: the failure of intelligence in business continuity at British Petroleum (BP), the problem of crisis communications in the management of the disaster at Trans World Airlines (TWA) Flight 800, and the incident involving a contaminated toothpaste product in GlaxoSmithKline (GSK).

 

KEYWORDS: Disaster and security management, British Petroleum, crisis communications, Trans World Airlines, GlaxoSmithKline,